| MNPR |
Monopar Therapeutics Inc. Common Stock |
$0.7947 |
66110 |
|
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants |
| RNA |
Avidity Biosciences Inc. Common Stock |
$10.2800 |
427900 |
|
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| TECH |
Bio-Techne Corp Common Stock |
$89.4200 |
1610000 |
|
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE |
| VNDA |
Vanda Pharmaceuticals Inc. Common Stock |
$6.5300 |
469820 |
|
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera |
| MTEM |
Molecular Templates Inc. Common Stock |
$0.5999 |
1010000 |
|
Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules |
| XOMA |
XOMA Corporation Common Stock |
$16.1500 |
21890 |
|
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 19, 2024 |
| VTRS |
Viatris Inc. Common Stock |
$10.6500 |
4880000 |
|
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology |
| IDYA |
IDEAYA Biosciences Inc. Common Stock |
$21.6200 |
254010 |
|
IDEAYA Announces IDMC Recommendation of Move-Forward Dose in Part 2a of Registration-Enabling Trial of Darovasertib and Crizotinib Combination in 1L HLA-A2-Negative Metastatic Uveal Melanoma |
| LPCN |
Lipocine Inc. Common Stock |
$4.4600 |
7580 |
|
FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis |
| SINT |
SiNtx Technologies Inc. Common Stock |
$1.7200 |
225050 |
|
SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications |
| SONN |
Sonnet BioTherapeutics Holdings Inc. Common Stock |
$0.3800 |
848070 |
|
Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update |
| XBIO |
Xenetic Biosciences Inc. Common Stock |
$4.1000 |
29260 |
|
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment |
| ZYXI |
Zynex Inc. Common Stock |
$9.1500 |
129160 |
|
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States |
| AWH |
Aspira Womens Health Inc. Common Stock |
$2.6400 |
144560 |
|
Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO |
| SNGX |
Soligenix Inc. Common Stock |
$0.6678 |
59980 |
|
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma |
| FBIO |
Fortress Biotech Inc. Common Stock |
$0.6099 |
5560000 |
|
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) |
| ATNF |
180 Life Sciences Corp. Common Stock |
$1.0418 |
27000 |
|
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules |
| NEO |
NeoGenomics Inc. Common Stock |
$16.6000 |
667120 |
|
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma |
| PRPH |
ProPhase Labs Inc. Common Stock (DE) |
$7.0200 |
19050 |
|
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures |
| CLRB |
Cellectar Biosciences Inc. Common Stock |
$2.1000 |
25400 |
|
Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring |
| CRIS |
Curis Inc. Common Stock |
$0.7921 |
122230 |
|
Curis Announces Additional Data from TakeAim Leukemia Study |
| VBIV |
VBI Vaccines Inc. New Common Stock (Canada) |
$1.4208 |
530730 |
|
VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission |
| ACHV |
Achieve Life Sciences Inc. Common Shares |
$5.3700 |
51960 |
|
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer |
| ARTL |
Artelo Biosciences Inc. Common Stock |
$1.9600 |
13890 |
|
Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia |
| BCLI |
Brainstorm Cell Therapeutics Inc. Common Stock |
$1.8400 |
92140 |
|
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update |
| KPTI |
Karyopharm Therapeutics Inc. Common Stock |
$1.6600 |
2410000 |
|
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications |
| RIGL |
Rigel Pharmaceuticals Inc. Common Stock |
$1.3200 |
978620 |
|
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition |
| RLMD |
Relmada Therapeutics Inc. Common Stock |
$2.8900 |
93490 |
|
Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017 |
| INSM |
Insmed Inc. Common Stock |
$21.0700 |
1100000 |
|
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| SNOA |
Sonoma Pharmaceuticals Inc. Common Stock |
$1.1400 |
18700 |
|
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices |
| DMAC |
DiaMedica Therapeutics Inc. Common Stock |
$3.6100 |
161740 |
|
DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia |
| NATR |
Natures Sunshine Products Inc. Common Stock |
$13.7600 |
22920 |
|
Nature’s Sunshine Partners with Cirque Series to Push Peaks 2025-2027 |
| AZYO |
Aziyo Biologics Inc. Class A Common Stock |
$6.4900 |
0 |
|
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc. |
| ALNY |
Alnylam Pharmaceuticals Inc. Common Stock |
$199.1700 |
305080 |
|
Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference |
| ATRA |
Atara Biotherapeutics Inc. Common Stock |
$2.0500 |
1480000 |
|
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference |
| TTNP |
Titan Pharmaceuticals Inc. Common Stock |
$0.5490 |
50160 |
|
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq |
| CABA |
Cabaletta Bio Inc. Common Stock |
$14.1400 |
208900 |
|
Cabaletta Bio to Participate in Upcoming Investor Conferences in December |
| GLSI |
Greenwich LifeSciences Inc. Common Stock |
$9.8900 |
13210 |
|
Greenwich LifeSciences Partners with GIM in Italy |
| IMUX |
Immunic Inc. Common Stock |
$2.5000 |
1050000 |
|
Immunic, Inc. to Participate in Investor Conference in December |
| STSA |
Satsuma Pharmaceuticals Inc. Common Stock |
$4.2200 |
13670 |
|
Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura |
| KRMD |
Repro Med Systems Inc. Common Stock |
$2.9300 |
64000 |
|
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference |
| ANIX |
Anixa Biosciences Inc. Common Stock |
$3.7000 |
113540 |
|
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset |
| CRBP |
Corbus Pharmaceuticals Holdings Inc. Common Stock |
$6.6300 |
25250 |
|
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference |
| LUMO |
Lumos Pharma Inc. Common Stock |
$3.1500 |
27610 |
|
Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months in PGHD and Correlation of Growth to LUM-201’s Unique Pulsatile Mechanism of Action |
| OPK |
OPKO Health Inc. Common Stock |
$2.0500 |
3120000 |
|
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference |
| NK |
NantKwest Inc. Common Stock |
$30.5000 |
55510 |
|
ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months |
| VKTX |
Viking Therapeutics Inc. Common Stock |
$15.2800 |
1630000 |
|
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 |
| VIRI |
Virios Therapeutics Inc. Common Stock |
$2.1400 |
745920 |
|
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study |
| ABEO |
Abeona Therapeutics Inc. Common Stock |
$3.7100 |
78160 |
|
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates |
| EVFM |
Evofem Biosciences Inc. Common Stock |
$0.8320 |
7420000 |
|
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 |
| GTBP |
GT Biopharma Inc. Common Stock |
$0.2740 |
368220 |
|
GT Biopharma Reports Third Quarter 2024 Financial Results |
| IKT |
Inhibikase Therapeutics Inc. Common Stock |
$2.7800 |
27220 |
|
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity |
| INBX |
Inhibrx Inc. Common Stock |
$24.2000 |
201460 |
|
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results |
| PBLA |
Panbela Therapeutics Inc. Common Stock |
$2.1700 |
489590 |
|
Panbela Provides Business Update and Reports Q3 2024 Financial Results |
| BSGM |
BioSig Technologies Inc. Common Stock |
$1.1900 |
2490000 |
|
BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement |
| COCP |
Cocrystal Pharma Inc. Common Stock |
$2.7300 |
19130 |
|
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs |
| PULM |
Pulmatrix Inc. Common Stock |
$2.5711 |
14410 |
|
Pulmatrix and Cullgen Announce Proposed Merger |
| VIRX |
Viracta Therapeutics Inc. Common Stock |
$1.5313 |
40820 |
|
Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update |
| CERC |
Cerecor Inc. Common Stock |
$0.0000 |
0 |
|
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants |
| RAPT |
RAPT Therapeutics Inc. Common Stock |
$22.6000 |
324250 |
|
RAPT Therapeutics Reports Third Quarter 2024 Financial Results |
| SYRS |
Syros Pharmaceuticals Inc. Common Stock |
$3.3900 |
49490 |
|
Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression |
| BYSI |
BeyondSpring Inc. Ordinary Shares |
$1.0790 |
69350 |
|
BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting |
| AXGN |
Axogen Inc. Common Stock |
$8.7600 |
121060 |
|
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update |
| INGN |
Inogen Inc Common Stock |
$8.7500 |
283660 |
|
Inogen Announces Third Quarter 2024 Financial Results |
| UTMD |
Utah Medical Products Inc. Common Stock |
$95.4300 |
9400 |
|
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend |
| OCUP |
Ocuphire Pharma Inc. Common Stock |
$4.0800 |
81550 |
|
Ocuphire Pharma Announces Acquisition of Opus Genetics |
| KTRA |
Kintara Therapeutics Inc. Common Stock |
$4.4700 |
11060 |
|
Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 |
| NEOG |
Neogen Corporation Common Stock |
$22.5600 |
2020000 |
|
Neogen Announces First-Quarter 2025 Results |
| BIOL |
Biolase Inc. Common Stock |
$0.0770 |
3400000 |
|
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
Oct 01, 2024 4:05pm EDT |
| GILD |
Gilead Sciences Inc. Common Stock |
$80.0000 |
14980000 |
|
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial |
| LIXT |
Lixte Biotechnology Holdings Inc. Common Stock |
$4.2500 |
81880 |
|
LIXTE Receives U.S. Patent Issue Notification for Immune Oncology |
| SIGA |
SIGA Technologies Inc. Common Stock |
$4.9600 |
341030 |
|
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics |
| GNPX |
Genprex Inc. Common Stock |
$0.8200 |
770520 |
|
Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials |
| APYX |
Apyx Medical Corporation Common Stock |
$5.9600 |
153250 |
|
RENUVION NAMED #1 TRUSTED BODY CONTOURING TECHNOLOGY BY DOCTORS*
August 13, 2024 |
| ATRI |
Atrion Corporation Common Stock |
$574.1600 |
4280 |
|
Atrion Reports Second Quarter 2024 Results |
| BNTC |
Benitec Biopharma Inc. Common Stock |
$0.2099 |
225460 |
|
Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study |
| TRVN |
Trevena Inc. Common Stock |
$0.9630 |
289130 |
|
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing |
| BBI |
Brickell Biotech Inc. Common Stock |
$2.9754 |
72330 |
|
Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company |
| ACET |
Adicet Bio Inc. Common Stock |
$3.0000 |
377940 |
|
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference |
| ALXO |
ALX Oncology Holdings Inc. Common Stock |
$6.4300 |
65950 |
|
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference Read more |
| NRIX |
Nurix Therapeutics Inc. Common stock |
$9.9900 |
464350 |
|
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference |
| PMVP |
PMV Pharmaceuticals Inc. Common Stock |
$6.7100 |
320870 |
|
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator |
| DYN |
Dyne Therapeutics Inc. Common Stock |
$11.1000 |
369460 |
|
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares |
| FHTX |
Foghorn Therapeutics Inc. Common Stock |
$8.1000 |
70730 |
|
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June |
| GTHX |
G1 Therapeutics Inc. Common Stock |
$2.4400 |
886650 |
|
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) |
| IONS |
Ionis Pharmaceuticals Inc. Common Stock |
$40.6500 |
2080000 |
|
Ionis to hold donidalorsen Phase 3 data webcast |
| OTLK |
Outlook Therapeutics Inc. Common Stock |
$1.6816 |
958890 |
|
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD |
| PHAT |
Phathom Pharmaceuticals Inc. Common Stock |
$14.3000 |
158780 |
|
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences |
| TGTX |
TG Therapeutics Inc. Common Stock |
$20.7200 |
3340000 |
|
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting |
| CNSP |
CNS Pharmaceuticals Inc. Common Stock |
$2.3300 |
63110 |
|
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results |
| STRO |
Sutro Biopharma Inc. Common Stock |
$4.7700 |
229940 |
|
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones |
| CODX |
Co-Diagnostics Inc. Common Stock |
$1.8500 |
321930 |
|
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results |
| EIGR |
Eiger BioPharmaceuticals Inc. Common Stock |
$0.7600 |
84400 |
|
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals |
| CLVR |
Clever Leaves Holdings Inc. Common Shares |
$0.2215 |
193940 |
|
Clever Leaves Announces Voluntary Delisting and SEC Deregistration |
| NBSE |
NeuBase Therapeutics Inc. Common Stock |
$1.8000 |
46740 |
|
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq |
| NXTC |
NextCure Inc. Common Stock |
$1.7602 |
10190 |
|
March 21, 2024 NextCure Provides Business Update and Reports Full Year 2023 Financial Results |
| GOVX |
GeoVax Labs Inc. Common Stock |
$0.5700 |
165960 |
|
GeoVax to Present at the 36th Annual Roth Conference |
| CRDF |
Cardiff Oncology Inc. Common Stock |
$1.5300 |
77580 |
|
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research |
| PAHC |
Phibro Animal Health Corporation Class A Common Stock |
$14.9400 |
59980 |
|
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance |
| PETQ |
PetIQ Inc. Class A Common Stock |
$16.0200 |
222280 |
|
PetIQ, Inc. Reports Third Quarter 2023 Financial Results |
| LGND |
Ligand Pharmaceuticals Incorporated Common Stock |
$69.1600 |
74440 |
|
Ligand’s Collaborator Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials |
| SIEN |
Sientra Inc. Common Stock |
$4.0800 |
332540 |
|
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023 |
| IRWD |
Ironwood Pharmaceuticals Inc. Class A Common Stock |
$10.6300 |
1380000 |
|
Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call |
| AEMD |
Aethlon Medical Inc. Common Stock |
$0.3800 |
198310 |
|
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant |
| BDSX |
Biodesix Inc. Common Stock |
$1.1700 |
243050 |
|
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 |
| LNSR |
LENSAR Inc. Common Stock |
$3.4200 |
9840 |
|
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups |
| APTX |
Aptinyx Inc. Common Stock |
$0.6220 |
126650 |
|
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies |
| ATRC |
AtriCure Inc. Common Stock |
$53.3000 |
330540 |
|
AtriCure to Announce First Quarter 2021 Financial Results |
| JAGX |
Jaguar Health Inc. Common Stock |
$0.5540 |
575330 |
|
Jaguar Health Promotes Carol Lizak to Chief Financial Officer
SAN FRANCISCO, CA / ACCESSWIRE / April 6, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that the Company has promoted Carol Lizak , an accomplished financial executive, to the expanded role of chief financial officer. |
| LABP |
Landos Biopharma Inc. Common Stock |
$0.8347 |
12840 |
|
Landos Biopharma Announces FDA Clearance of IND Application for Omilancor for the Treatment of Eosinophilic Esophagitis |
| OLMA |
Olema Pharmaceuticals Inc. Common Stock |
$9.0000 |
303230 |
|
Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors |
| VIR |
Vir Biotechnology Inc. Common Stock |
$14.1100 |
6140000 |
|
Vir Biotechnology to Present at the 20th Annual Needham Virtual Healthcare Conference |
| ACAD |
ACADIA Pharmaceuticals Inc. Common Stock |
$31.2500 |
2760000 |
|
Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis |
| BPMC |
Blueprint Medicines Corporation Common Stock |
$58.7600 |
875700 |
|
Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021 |
| CDTX |
Cidara Therapeutics Inc. Common Stock |
$1.0200 |
2540000 |
|
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza |
| CLSD |
Clearside Biomedical Inc. Common Stock |
$1.2900 |
34230 |
|
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit |
| EXEL |
Exelixis Inc. Common Stock |
$19.7900 |
1660000 |
|
Exelixis Announces U.S. FDA Accepts Investigational New Drug Application for XB002 in Patients with Advanced Solid Tumors |
| GMTX |
Gemini Therapeutics Inc. Common Stock |
$1.5400 |
24650 |
|
GATX Corporation Sets Date for 2021 First Quarter Earnings Release and Conference Call
CHICAGO , April 05, 2021 (GLOBE NEWSWIRE) -- GATX Corporation (NYSE:GATX) will report results for the 2021 first quarter prior to market open on April 20, 2021 . GATX will hold a conference call to review the results later that morning. Investors may listen to the call via telephone or over the |
| SELB |
Selecta Biosciences Inc. Common Stock |
$1.1500 |
451010 |
|
Selecta Biosciences to Participate at the 20th Annual Needham Healthcare Conference |
| ABIO |
ARCA biopharma Inc. Common Stock |
$4.5200 |
2529584 |
|
|
| ABMD |
ABIOMED Inc. Common Stock |
$325.3100 |
199237 |
|
|
| ACER |
Acer Therapeutics Inc. Common Stock (DE) |
$0.8495 |
67250 |
|
|
| ACHC |
Acadia Healthcare Company Inc. Common Stock |
$55.8000 |
1061396 |
|
|
| ACOR |
Acorda Therapeutics Inc. Common Stock |
$6.1900 |
187378 |
|
|
| ACRS |
Aclaris Therapeutics Inc. Common Stock |
$10.9200 |
576400 |
|
|
| ACRX |
AcelRx Pharmaceuticals Inc. Common Stock |
$1.0300 |
140990 |
|
|
| ADIL |
Adial Pharmaceuticals Inc Common Stock |
$0.2683 |
274960 |
|
|
| ADILW |
Adial Pharmaceuticals Inc Warrant |
$0.6600 |
254 |
|
|
| ADMA |
ADMA Biologics Inc Common Stock |
$3.7300 |
1330000 |
|
|
| ADMP |
Adamis Pharmaceuticals Corporation Common Stock |
$1.9500 |
121140 |
|
|
| ADMS |
Adamas Pharmaceuticals Inc. Common Stock |
$5.2600 |
668802 |
|
|
| ADPT |
Adaptive Biotechnologies Corporation Common Stock |
$8.0000 |
961260 |
|
|
| ADTX |
ADiTx Therapeutics Inc. Common Stock |
$3.2200 |
309638 |
|
|
| ADUS |
Addus HomeCare Corporation Common Stock |
$104.1300 |
169625 |
|
|
| ADVM |
Adverum Biotechnologies Inc. Common Stock |
$2.1000 |
904170 |
|
|
| ADXS |
Advaxis Inc. Common Stock |
$3.8500 |
6090 |
|
|
| AERI |
Aerie Pharmaceuticals Inc. Common Stock |
$7.7800 |
83680 |
|
|
| AFIB |
Acutus Medical Inc. Common Stock |
$0.7313 |
101570 |
|
|
| AGEN |
Agenus Inc. Common Stock |
$1.6300 |
3480000 |
|
|
| AGIO |
Agios Pharmaceuticals Inc. Common Stock |
$27.5200 |
844340 |
|
|
| AGLE |
Aeglea BioTherapeutics Inc. Common Stock |
$7.7500 |
147074 |
|
|
| AGRX |
Agile Therapeutics Inc. Common Stock |
$3.0300 |
17220 |
|
|
| AGTC |
Applied Genetic Technologies Corporation Common Stock |
$0.3808 |
1570000 |
|
|
| AHCO |
AdaptHealth Corp. Class A Common Stock |
$13.9700 |
659380 |
|
|
| AHPI |
Allied Healthcare Products Inc. Common Stock |
$4.9400 |
126774 |
|
|
| AIKI |
AIkido Pharma Inc. Common Stock |
$1.2100 |
8073352 |
|
|
| AKBA |
Akebia Therapeutics Inc. Common Stock |
$1.2900 |
1020000 |
|
|
| AKER |
Akers Biosciences Inc. Common Stock |
$3.0100 |
530413 |
|
|
| AKRO |
Akero Therapeutics Inc. Common Stock |
$45.0900 |
444300 |
|
|
| AKUS |
Akouos Inc. Common Stock |
$3.2500 |
192270 |
|
|
| ALBO |
Albireo Pharma Inc. Common Stock |
$23.4000 |
114920 |
|
|
| ALDX |
Aldeyra Therapeutics Inc. Common Stock |
$8.0400 |
659190 |
|
|
| ALEC |
Alector Inc. Common Stock |
$6.7900 |
455880 |
|
|
| ALGN |
Align Technology Inc. Common Stock |
$337.7000 |
1570000 |
|
|
| ALGS |
Aligos Therapeutics Inc. Common Stock |
$0.9500 |
62660 |
|
|
| ALIM |
Alimera Sciences Inc. Common Stock |
$9.0000 |
91306 |
|
|
| ALLK |
Allakos Inc. Common Stock |
$4.8300 |
490050 |
|
|
| ALLO |
Allogene Therapeutics Inc. Common Stock |
$5.5000 |
1630000 |
|
|
| ALNA |
Allena Pharmaceuticals Inc. Common Stock |
$0.1250 |
17600000 |
|
|
| ALPN |
Alpine Immune Sciences Inc. Common Stock |
$13.2600 |
159419 |
|
|
| ALRN |
Aileron Therapeutics Inc. Common Stock |
$1.8700 |
46550 |
|
|
| ALT |
Altimmune Inc. Common Stock |
$3.1598 |
1170000 |
|
|
| ALVR |
AlloVir Inc. Common Stock |
$3.5800 |
535180 |
|
|
| ALXN |
Alexion Pharmaceuticals Inc. Common Stock |
$150.3700 |
2346055 |
|
|
| AMED |
Amedisys Inc Common Stock |
$252.5300 |
209738 |
|
|
| AMGN |
Amgen Inc. Common Stock |
$225.6900 |
2404082 |
|
|
| AMPH |
Amphastar Pharmaceuticals Inc. Common Stock |
$63.4700 |
588810 |
|
|
| AMTI |
Applied Molecular Transport Inc. Common Stock |
$0.3169 |
14860 |
|
|
| ANAB |
AnaptysBio Inc. Common Stock |
$18.1200 |
181650 |
|
|
| ANGN |
Angion Biomedica Corp. Common Stock |
$1.1000 |
185350 |
|
|
| ANGO |
AngioDynamics Inc. Common Stock |
$8.9100 |
553220 |
|
|
| ANIK |
Anika Therapeutics Inc. Common Stock |
$25.3400 |
50840 |
|
|
| ANIP |
ANI Pharmaceuticals Inc. |
$52.1900 |
82370 |
|
|
| ANNX |
Annexon Inc. Common Stock |
$3.4400 |
396130 |
|
|
| APEN |
Apollo Endosurgery Inc. Common Stock |
$6.3100 |
2274622 |
|
|
| APLS |
Apellis Pharmaceuticals Inc. Common Stock |
$34.4600 |
5670000 |
|
|
| APLT |
Applied Therapeutics Inc. Common Stock |
$1.4700 |
150150 |
|
|
| APR |
Apria Inc. Common Stock |
$21.5700 |
261646 |
|
|
| APRE |
Aprea Therapeutics Inc. Common stock |
$5.9100 |
543340 |
|
|
| APVO |
Aptevo Therapeutics Inc. Common Stock |
$1.0900 |
693300 |
|
|
| AQST |
Aquestive Therapeutics Inc. Common Stock |
$1.6300 |
225100 |
|
|
| ARAV |
Aravive Inc. Common Stock |
$1.6900 |
477430 |
|
|
| ARAY |
Accuray Incorporated Common Stock |
$3.7900 |
423280 |
|
|
| ARDS |
Aridis Pharmaceuticals Inc. Common Stock |
$1.2436 |
64200 |
|
|
| ARDX |
Ardelyx Inc. Common Stock |
$3.5100 |
2450000 |
|
|
| ARNA |
Arena Pharmaceuticals Inc. Common Stock |
$76.8100 |
623315 |
|
|
| ARPO |
Aerpio Pharmaceuticals Inc. Common Stock |
$1.7400 |
595612 |
|
|
| ARQT |
Arcutis Biotherapeutics Inc. Common Stock |
$10.9300 |
967850 |
|
|
| ARTLW |
Artelo Biosciences Inc. Warrant |
$0.4601 |
15390 |
|
|
| ARVN |
Arvinas Inc. Common Stock |
$24.0000 |
220510 |
|
|
| ARWR |
Arrowhead Pharmaceuticals Inc. Common Stock |
$35.9900 |
964300 |
|
|
| ASMB |
Assembly Biosciences Inc. Common Stock |
$2.2850 |
208410 |
|
|
| ASRT |
Assertio Holdings Inc. Common Stock |
$5.3500 |
644250 |
|
|
| ATEC |
Alphatec Holdings Inc. Common Stock |
$16.8100 |
441895 |
|
|
| ATHA |
Athira Pharma Inc. Common Stock |
$3.1600 |
151010 |
|
|
| ATHX |
Athersys Inc. Common Stock |
$2.0100 |
2162711 |
|
|
| ATNFW |
180 Life Sciences Corp. Warrant |
$0.8410 |
70584 |
|
|
| ATNX |
Athenex Inc. Common Stock |
$0.5778 |
273480 |
|
|
| ATOS |
Atossa Therapeutics Inc. Common Stock |
$1.1092 |
561130 |
|
|
| ATRS |
Antares Pharma Inc. Common Stock |
$4.0600 |
3102456 |
|
|
| ATXI |
Avenue Therapeutics Inc. Common Stock |
$0.2703 |
72050 |
|
|
| AVEO |
AVEO Pharmaceuticals Inc. Common Stock |
$6.9300 |
106940 |
|
|
| AVGR |
Avinger Inc. Common Stock |
$1.7100 |
6197414 |
|
|
| AVIR |
Atea Pharmaceuticals Inc. Common Stock |
$3.6600 |
307630 |
|
|
| AVRO |
AVROBIO Inc. Common Stock |
$1.4900 |
1090000 |
|
|
| AVXL |
Anavex Life Sciences Corp. Common Stock |
$8.1000 |
778050 |
|
|
| AXLA |
Axcella Health Inc. Common Stock |
$0.1821 |
164220 |
|
|
| AXNX |
Axonics Modulation Technologies Inc. Common Stock |
$54.2200 |
884010 |
|
|
| AXSM |
Axsome Therapeutics Inc. Common Stock |
$76.8600 |
1090000 |
|
|
| AYTU |
Aytu BioScience Inc. Common Stock |
$7.8400 |
272602 |
|
|
| AZRX |
AzurRx BioPharma Inc. Common Stock |
$1.3900 |
1419189 |
|
|
| BASI |
Bioanalytical Systems Inc. Common Stock |
$20.1400 |
219219 |
|
|
| BBIO |
BridgeBio Pharma Inc. Common Stock |
$34.3900 |
2800000 |
|
|
| BCAB |
BioAtla Inc. Common Stock |
$2.9300 |
169950 |
|
|
| BCDA |
BioCardia Inc. Common Stock |
$3.9300 |
101228 |
|
|
| BCDAW |
BioCardia Inc. Warrant |
$1.3001 |
11 |
|
|
| BCEL |
Atreca Inc. Class A Common Stock |
$1.0900 |
171580 |
|
|
| BCRX |
BioCryst Pharmaceuticals Inc. Common Stock |
$7.4800 |
1840000 |
|
|
| BDSI |
BioDelivery Sciences International Inc. Common Stock |
$0.1300 |
0 |
|
|
| BDTX |
Black Diamond Therapeutics Inc. Common Stock |
$4.5200 |
1760000 |
|
|
| BEAM |
Beam Therapeutics Inc. Common Stock |
$31.5800 |
879470 |
|
|
| BIIB |
Biogen Inc. Common Stock |
$277.8000 |
2830000 |
|
|
| BIOC |
Biocept Inc. Common Stock |
$1.2800 |
141270 |
|
|
| BIVI |
BioVie Inc. Class A Common Stock |
$26.0600 |
165680 |
|
|
| BLCM |
Bellicum Pharmaceuticals Inc. Common Stock |
$1.2200 |
22430 |
|
|
| BLFS |
BioLife Solutions Inc. Common Stock |
$20.0700 |
233590 |
|
|
| BLPH |
Bellerophon Therapeutics Inc. Common Stock |
$0.7214 |
180370 |
|
|
| BLUE |
bluebird bio Inc. Common Stock |
$30.8000 |
2977206 |
|
|
| BMRA |
Biomerica Inc. Common Stock |
$6.1900 |
50748 |
|
|
| BMRN |
BioMarin Pharmaceutical Inc. Common Stock |
$87.7200 |
1210000 |
|
|
| BOLT |
Bolt Biotherapeutics Inc. Common Stock |
$1.3500 |
102070 |
|
|
| BPTH |
Bio-Path Holdings Inc. Common Stock |
$1.2400 |
56470 |
|
|
| BRPA |
Big Rock Partners Acquisition Corp. Common Stock |
$34.3100 |
13284 |
|
|
| BRPAR |
Big Rock Partners Acquisition Corp. Right |
$2.0500 |
68752 |
|
|
| BRPAU |
Big Rock Partners Acquisition Corp. Unit |
$67.0000 |
85 |
|
|
| BRPAW |
Big Rock Partners Acquisition Corp. Warrant |
$8.7000 |
53992 |
|
|
| BTAI |
BioXcel Therapeutics Inc. Common Stock |
$10.9200 |
1080000 |
|
|
| BVS |
Bioventus Inc. Class A Common Stock |
$3.5300 |
188300 |
|
|
| BXRX |
Baudax Bio Inc. Common Stock |
$0.8240 |
135850 |
|
|
| CALA |
Calithera Biosciences Inc. Common Stock |
$3.3300 |
60200 |
|
|
| CAPR |
Capricor Therapeutics Inc. Common Stock |
$5.7400 |
295501 |
|
|
| CARA |
Cara Therapeutics Inc. Common Stock |
$2.9000 |
440160 |
|
|
| CASI |
CASI Pharmaceuticals Inc. Common Stock |
$2.4700 |
360603 |
|
|
| CATB |
Catabasis Pharmaceuticals Inc. Common Stock |
$32.8000 |
29020 |
|
|
| CBAY |
CymaBay Therapeutics Inc. Common Stock |
$11.6900 |
856480 |
|
|
| CBIO |
Catalyst Biosciences Inc. Common Stock |
$0.4488 |
572780 |
|
|
| CBLI |
Cleveland BioLabs Inc. Common Stock |
$6.0500 |
224639 |
|
|
| CCCC |
C4 Therapeutics Inc. Common Stock |
$3.8300 |
518539 |
|
|
| CCXI |
ChemoCentryx Inc. Common Stock |
$23.0000 |
408550 |
|
|
| CDAK |
Codiak BioSciences Inc. Common Stock |
$2.6200 |
57320 |
|
|
| CDMO |
Avid Bioservices Inc. Common Stock |
$13.6600 |
961770 |
|
|
| CDMOP |
Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock |
$30.9500 |
6283 |
|
|
| CDNA |
CareDx Inc. Common Stock |
$10.8200 |
803840 |
|
|
| CELC |
Celcuity Inc. Common Stock |
$15.4000 |
29768 |
|
|
| CEMI |
Chembio Diagnostics Inc. Common Stock |
$5.4300 |
432683 |
|
|
| CERE |
Cerevel Therapeutics Holdings Inc. Common Stock |
$29.4900 |
335440 |
|
|
| CEREW |
Cerevel Therapeutics Holdings Inc. Warrant |
$5.0000 |
900 |
|
|
| CERS |
Cerus Corporation Common Stock |
$6.4600 |
3519745 |
|
|
| CFMS |
Conformis Inc. Common Stock |
$2.1800 |
41180 |
|
|
| CFRX |
ContraFect Corporation Common Stock |
$1.2001 |
54300 |
|
|
| CGEM |
Cullinan Oncology Inc. Common Stock |
$10.4700 |
81100 |
|
|
| CGIX |
Cancer Genetics Inc. Common Stock |
$5.8900 |
478509 |
|
|
| CHFS |
CHF Solutions Inc. Common Stock |
$8.9700 |
15398858 |
|
|
| CHMA |
Chiasma Inc. Common Stock |
$3.9900 |
1163453 |
|
|
| CHRS |
Coherus BioSciences Inc. Common Stock |
$4.3500 |
1550000 |
|
|
| CKPT |
Checkpoint Therapeutics Inc. Common Stock |
$3.3400 |
1262360 |
|
|
| CLBS |
Caladrius Biosciences Inc. Common Stock |
$1.8600 |
1979426 |
|
|
| CLDX |
Celldex Therapeutics Inc. |
$37.1400 |
315630 |
|
|
| CLNN |
Clene Inc. Common Stock |
$13.7600 |
143780 |
|
|
| CLNNW |
Clene Inc. Warrant |
$1.3900 |
159620 |
|
|
| CLOV |
Clover Health Investments Corp. Class A Common Stock |
$1.1800 |
3950000 |
|
|
| CLOVW |
Clover Health Investments Corp. Warrants |
$2.3820 |
592207 |
|
|
| CLPT |
ClearPoint Neuro Inc. Common Stock |
$6.7900 |
49160 |
|
|
| CLRBZ |
Cellectar Biosciences Inc. Series A Warrants |
$0.3000 |
44957 |
|
|
| CLSN |
Celsion Corporation Common Stock |
$2.1700 |
27940 |
|
|
| CLVRW |
Clever Leaves Holdings Inc. Warrant |
$4.7300 |
364266 |
|
|
| CLVS |
Clovis Oncology Inc. Common Stock |
$1.7793 |
2830000 |
|
|
| CMPI |
Checkmate Pharmaceuticals Inc. Common Stock |
$14.6500 |
19975 |
|
|
| CMRX |
Chimerix Inc. Common Stock |
$1.1913 |
558620 |
|
|
| CNCE |
Concert Pharmaceuticals Inc. Common Stock |
$4.7800 |
153700 |
|
|
| CNST |
Constellation Pharmaceuticals Inc. Common Stock |
$24.9800 |
374522 |
|
|
| COGT |
Cogent Biosciences Inc. Common Stock |
$12.0000 |
328850 |
|
|
| COLL |
Collegium Pharmaceutical Inc. Common Stock |
$22.6100 |
249880 |
|
|
| CORT |
Corcept Therapeutics Incorporated Common Stock |
$24.2000 |
522940 |
|
|
| CPIX |
Cumberland Pharmaceuticals Inc. Common Stock |
$1.5500 |
8380 |
|
|
| CPRX |
Catalyst Pharmaceuticals Inc. Common Stock |
$13.6100 |
991070 |
|
|
| CRMD |
CorMedix Inc. Common Stock |
$3.8804 |
749520 |
|
|
| CRNX |
Crinetics Pharmaceuticals Inc. Common Stock |
$18.1500 |
429480 |
|
|
| CRTX |
Cortexyme Inc. Common Stock |
$1.8800 |
146980 |
|
|
| CRVS |
Corvus Pharmaceuticals Inc. Common Stock |
$2.7550 |
110570 |
|
|
| CSBR |
Champions Oncology Inc. Common Stock |
$12.2100 |
72661 |
|
|
| CSII |
Cardiovascular Systems Inc. Common Stock |
$41.3800 |
131731 |
|
|
| CSTL |
Castle Biosciences Inc. Common Stock |
$16.7300 |
245840 |
|
|
| CTIC |
CTI BioPharma Corp. (DE) Common Stock |
$6.1100 |
2300000 |
|
|
| CTMX |
CytomX Therapeutics Inc. Common Stock |
$1.8100 |
143460 |
|
|
| CTSO |
Cytosorbents Corporation Common Stock |
$3.6000 |
28240 |
|
|
| CTXR |
Citius Pharmaceuticals Inc. Common Stock |
$1.1892 |
871520 |
|
|
| CTXRW |
Citius Pharmaceuticals Inc. Warrant |
$1.2000 |
38586 |
|
|
| CUE |
Cue Biopharma Inc. Common Stock |
$13.0000 |
151216 |
|
|
| CUTR |
Cutera Inc. Common Stock |
$16.2900 |
373220 |
|
|
| CVET |
Covetrus Inc. Common Stock |
$20.7500 |
391710 |
|
|
| CWBR |
CohBar Inc. Common Stock |
$2.9700 |
8970 |
|
|
| CYCC |
Cyclacel Pharmaceuticals Inc. Common Stock |
$0.6904 |
17240 |
|
|
| CYCN |
Cyclerion Therapeutics Inc. Common Stock |
$0.7744 |
43990 |
|
|
| CYRX |
CryoPort Inc. Common Stock |
$15.9100 |
831970 |
|
|
| CYTK |
Cytokinetics Incorporated Common Stock |
$33.3200 |
1100000 |
|
|
| DARE |
Dare Bioscience Inc. Common Stock |
$0.7701 |
737870 |
|
|
| DBTX |
Decibel Therapeutics Inc. Common Stock |
$3.0300 |
22050 |
|
|
| DCPH |
Deciphera Pharmaceuticals Inc. Common Stock |
$13.7100 |
269800 |
|
|
| DCTH |
Delcath Systems Inc. Common Stock |
$19.2800 |
57631 |
|
|
| DFFN |
Diffusion Pharmaceuticals Inc. Common Stock |
$1.0600 |
5480588 |
|
|
| DFHT |
Deerfield Healthcare Technology Acquisitions Corp. Class A Common Stock |
$12.6500 |
21365 |
|
|
| DFHTU |
Deerfield Healthcare Technology Acquisitions Corp. Unit |
$13.0100 |
8017 |
|
|
| DFHTW |
Deerfield Healthcare Technology Acquisitions Corp. Warrant |
$2.7700 |
543 |
|
|
| DMTK |
DermTech Inc. Common Stock |
$3.7800 |
288770 |
|
|
| DNLI |
Denali Therapeutics Inc. Common Stock |
$62.9200 |
562114 |
|
|
| DRNA |
Dicerna Pharmaceuticals Inc. Common Stock |
$29.5100 |
1905326 |
|
|
| DRRX |
DURECT Corporation Common Stock |
$3.1800 |
785390 |
|
|
| DTIL |
Precision BioSciences Inc. Common Stock |
$0.6411 |
655820 |
|
|
| DVAX |
Dynavax Technologies Corporation Common Stock |
$14.4800 |
1230000 |
|
|
| DXCM |
DexCom Inc. Common Stock |
$130.6000 |
7300000 |
|
|
| DYAI |
Dyadic International Inc. Common Stock |
$5.4100 |
166016 |
|
|
| DYNT |
Dynatronics Corporation Common Stock |
$1.2800 |
1526367 |
|
|
| EAR |
Eargo Inc. Common Stock |
$4.2200 |
12220 |
|
|
| ECOR |
electroCore Inc. Common Stock |
$0.5750 |
45750 |
|
|
| EDIT |
Editas Medicine Inc. Common Stock |
$8.9400 |
1240000 |
|
|
| EDSA |
Edesa Biotech Inc. Common Shares |
$5.6400 |
150302 |
|
|
| EGRX |
Eagle Pharmaceuticals Inc. Common Stock |
$40.4000 |
185525 |
|
|
| ELDN |
Eledon Pharmaceuticals Inc. Common Stock |
$2.8800 |
5170 |
|
|
| ELOX |
Eloxx Pharmaceuticals Inc. Common Stock |
$6.5700 |
112370 |
|
|
| ENOB |
Enochian Biosciences Inc. Common Stock |
$3.6400 |
39426 |
|
|
| ENSG |
The Ensign Group Inc. Common Stock |
$91.9500 |
314000 |
|
|
| ENTA |
Enanta Pharmaceuticals Inc. Common Stock |
$49.9200 |
663252 |
|
|
| EOLS |
Evolus Inc. Common Stock |
$7.0800 |
457110 |
|
|
| EPZM |
Epizyme Inc. Common Stock |
$1.4803 |
431260 |
|
|
| EQ |
Equillium Inc. Common Stock |
$0.8404 |
56610 |
|
|
| ESPR |
Esperion Therapeutics Inc. Common Stock |
$27.7600 |
684953 |
|
|
| ETNB |
89bio Inc. Common Stock |
$17.4300 |
738580 |
|
|
| ETON |
Eton Pharmaceuticals Inc. Common Stock |
$2.6920 |
43650 |
|
|
| ETTX |
Entasis Therapeutics Holdings Inc. Common Stock |
$2.6800 |
230301 |
|
|
| EVLO |
Evelo Biosciences Inc. Common Stock |
$11.3700 |
4950000 |
|
|
| EVOK |
Evoke Pharma Inc. Common Stock |
$3.0500 |
23750 |
|
|
| EXAS |
Exact Sciences Corporation Common Stock |
$136.3900 |
1634654 |
|
|
| EYE |
National Vision Holdings Inc. Common Stock |
$24.1000 |
745890 |
|
|
| EYEG |
Eyegate Pharmaceuticals Inc. Common Stock |
$5.5700 |
36946 |
|
|
| EYEN |
Eyenovia Inc. Common Stock |
$2.3000 |
225900 |
|
|
| EYES |
Second Sight Medical Products Inc. Common Stock |
$1.9210 |
53800 |
|
|
| EYESW |
Second Sight Medical Products Inc. Warrants expiring 03/14/2024 |
$0.3600 |
8660 |
|
|
| FATE |
Fate Therapeutics Inc. Common Stock |
$4.6700 |
1320000 |
|
|
| FBIOP |
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock |
$22.9500 |
46410 |
|
|
| FBRX |
Forte Biosciences Inc. Common Stock |
$1.2450 |
454990 |
|
|
| FCAC |
Falcon Capital Acquisition Corp. Class A Common Stock |
$10.7600 |
946104 |
|
|
| FCACU |
Falcon Capital Acquisition Corp. Unit |
$11.4100 |
30964 |
|
|
| FCACW |
Falcon Capital Acquisition Corp. Warrant |
$2.0000 |
159499 |
|
|
| FDMT |
4D Molecular Therapeutics Inc. Common Stock |
$17.4000 |
171090 |
|
|
| FENC |
Fennec Pharmaceuticals Inc. Common Stock |
$8.5800 |
70250 |
|
|
| FGEN |
FibroGen Inc Common Stock |
$2.1400 |
7090000 |
|
|
| FIXX |
Homology Medicines Inc. Common Stock |
$1.0900 |
115230 |
|
|
| FLGT |
Fulgent Genetics Inc. Common Stock |
$39.5100 |
145400 |
|
|
| FLXN |
Flexion Therapeutics Inc. Common Stock |
$11.0800 |
419345 |
|
|
| FMTX |
Forma Therapeutics Holdings Inc. Common Stock |
$8.0500 |
631320 |
|
|
| FOLD |
Amicus Therapeutics Inc. Common Stock |
$13.9000 |
3160000 |
|
|
| FONR |
Fonar Corporation Common Stock |
$20.0000 |
45456 |
|
|
| FPRX |
Five Prime Therapeutics Inc. Common Stock |
$22.3100 |
517503 |
|
|
| FREQ |
Frequency Therapeutics Inc. Common Stock |
$0.5800 |
385260 |
|
|
| FSTX |
F-star Therapeutics Inc. Common Stock |
$6.1700 |
86390 |
|
|
| FULC |
Fulcrum Therapeutics Inc. Common Stock |
$4.0400 |
438090 |
|
|
| FVE |
Five Star Senior Living Inc. Common Stock |
$0.3700 |
17890 |
|
|
| GALT |
Galectin Therapeutics Inc. Common Stock |
$1.6100 |
35790 |
|
|
| GBIO |
Generation Bio Co. Common Stock |
$5.3300 |
121590 |
|
|
| GBS |
GBS Inc. Common Stock |
$0.7047 |
27850 |
|
|
| GBT |
Global Blood Therapeutics Inc. Common Stock |
$33.8300 |
462520 |
|
|
| GERN |
Geron Corporation Common Stock |
$1.7800 |
2833716 |
|
|
| GH |
Guardant Health Inc. Common Stock |
$37.6400 |
1400000 |
|
|
| GHSI |
Guardion Health Sciences Inc. Common Stock |
$2.5000 |
2940324 |
|
|
| GLYC |
GlycoMimetics Inc. Common Stock |
$1.6467 |
110370 |
|
|
| GNCA |
Genocea Biosciences Inc. Common Stock |
$0.0119 |
234440 |
|
|
| GNMK |
GenMark Diagnostics Inc. Common Stock |
$18.9400 |
791784 |
|
|
| GOSS |
Gossamer Bio Inc. Common Stock |
$1.3900 |
7990000 |
|
|
| GOVXW |
GeoVax Labs Inc. Warrants |
$1.9999 |
1810 |
|
|
| GRAY |
Graybug Vision Inc. Common Stock |
$0.9780 |
23660 |
|
|
| GRNV |
GreenVision Acquisition Corp Common stock |
$10.1801 |
85442 |
|
|
| GRNVR |
GreenVision Acquisition Corp Rights |
$0.5190 |
75087 |
|
|
| GRNVU |
GreenVision Acquisition Corp Unit |
$11.9600 |
457 |
|
|
| GRNVW |
GreenVision Acquisition Corp Warrant |
$1.1000 |
75460 |
|
|
| GRTS |
Gritstone Oncology Inc. Common Stock |
$2.1700 |
335840 |
|
|
| GRTX |
Galera Therapeutics Inc. Common Stock |
$2.7800 |
725350 |
|
|
| GXGX |
GX Acquisiton Corp. Class A Common Stock |
$10.0800 |
665004 |
|
|
| GXGXU |
GX Acquisiton Corp. Unit |
$10.7700 |
1 |
|
|
| GXGXW |
GX Acquisiton Corp. Warrant |
$1.7300 |
91980 |
|
|
| HALO |
Halozyme Therapeutics Inc. Common Stock |
$42.8900 |
1130000 |
|
|
| HARP |
Harpoon Therapeutics Inc. Common Stock |
$0.8300 |
466140 |
|
|
| HCSG |
Healthcare Services Group Inc. Common Stock |
$14.5200 |
2150000 |
|
|
| HEC |
Hudson Executive Investment Corp. Class A Common Stock |
$10.5700 |
1305657 |
|
|
| HECCU |
Hudson Executive Investment Corp. Units |
$11.5500 |
9851 |
|
|
| HECCW |
Hudson Executive Investment Corp. Warrant |
$1.9000 |
443367 |
|
|
| HEPA |
Hepion Pharmaceuticals Inc. Common Stock |
$9.3700 |
33070 |
|
|
| HGEN |
Humanigen Inc. Common Stock |
$17.6900 |
1597877 |
|
|
| HJLI |
Hancock Jaffe Laboratories Inc. Common Stock |
$7.3100 |
688419 |
|
|
| HJLIW |
Hancock Jaffe Laboratories Inc. Warrants |
$0.4100 |
32332 |
|
|
| HOLX |
Hologic Inc. Common Stock |
$74.8200 |
1467402 |
|
|
| HOOK |
HOOKIPA Pharma Inc. Common Stock |
$0.8700 |
359260 |
|
|
| HOTH |
Hoth Therapeutics Inc. Common Stock |
$2.6700 |
39730 |
|
|
| HRMY |
Harmony Biosciences Holdings Inc. Common Stock |
$35.6100 |
370300 |
|
|
| HROW |
Harrow Health Inc. Common Stock |
$7.9700 |
211984 |
|
|
| HRTX |
Heron Therapeutics Inc. Common Stock |
$1.3700 |
1440000 |
|
|
| HSDT |
Helius Medical Technologies Inc. Class A Common Stock (DE) |
$0.1980 |
228930 |
|
|
| HSIC |
Henry Schein Inc. Common Stock |
$79.9200 |
718700 |
|
|
| HSKA |
Heska Corporation Common Stock |
$188.6900 |
82594 |
|
|
| HSTO |
Histogen Inc. Common Stock |
$0.8295 |
19570 |
|
|
| HTBX |
Heat Biologics Inc. Common Stock |
$7.8700 |
612986 |
|
|
| IART |
Integra LifeSciences Holdings Corporation Common Stock |
$44.8500 |
757920 |
|
|
| ICAD |
iCAD Inc. Common Stock |
$18.7900 |
76844 |
|
|
| ICCC |
ImmuCell Corporation Common Stock |
$5.3800 |
38860 |
|
|
| ICPT |
Intercept Pharmaceuticals Inc. Common Stock |
$10.5500 |
738500 |
|
|
| ICUI |
ICU Medical Inc. Common Stock |
$176.3500 |
202050 |
|
|
| IDRA |
Idera Pharmaceuticals Inc. Common Stock |
$4.7000 |
628926 |
|
|
| IDXX |
IDEXX Laboratories Inc. Common Stock |
$529.4700 |
292171 |
|
|
| IGMS |
IGM Biosciences Inc. Common Stock |
$10.3800 |
128400 |
|
|
| IMAC |
IMAC Holdings Inc. Common Stock |
$0.9800 |
360830 |
|
|
| IMACW |
IMAC Holdings Inc. Warrant |
$0.5560 |
1082 |
|
|
| IMGN |
ImmunoGen Inc. Common Stock |
$18.9900 |
2340000 |
|
|
| IMNM |
Immunome Inc. Common Stock |
$7.1200 |
148750 |
|
|
| IMRA |
IMARA Inc. Common Stock |
$1.1600 |
27140 |
|
|
| IMVT |
Immunovant Inc. Common Stock |
$22.2800 |
920660 |
|
|
| INCY |
Incyte Corp. Common Stock |
$78.5600 |
788099 |
|
|
| INFI |
Infinity Pharmaceuticals Inc. Common Stock |
$0.2269 |
911430 |
|
|
| INMB |
INmune Bio Inc. Common stock |
$8.5000 |
50830 |
|
|
| INO |
Inovio Pharmaceuticals Inc. Common Stock |
$10.0200 |
20615006 |
|
|
| INVA |
Innoviva Inc. Common Stock |
$12.9500 |
417600 |
|
|
| INVO |
INVO BioScience Inc. Common Stock |
$0.1692 |
235670 |
|
|
| INZY |
Inozyme Pharma Inc. Common Stock |
$6.9200 |
627390 |
|
|
| IOVA |
Iovance Biotherapeutics Inc. Common Stock |
$7.6000 |
3350000 |
|
|
| IRIX |
IRIDEX Corporation Common Stock |
$2.0600 |
11760 |
|
|
| IRMD |
iRadimed Corporation Common Stock |
$46.1700 |
27480 |
|
|
| IRTC |
iRhythm Technologies Inc. Common Stock |
$103.2100 |
278080 |
|
|
| ISEE |
IVERIC bio Inc. Common Stock |
$11.0800 |
1360000 |
|
|
| ISRG |
Intuitive Surgical Inc. Common Stock |
$337.6300 |
9160000 |
|
|
| ITCI |
Intra-Cellular Therapies Inc. Common Stock |
$62.0800 |
598180 |
|
|
| ITOS |
iTeos Therapeutics Inc. Common Stock |
$14.5500 |
246800 |
|
|
| JNCE |
Jounce Therapeutics Inc. Common Stock |
$12.7700 |
300557 |
|
|
| KALA |
Kala Pharmaceuticals Inc. Common Stock |
$14.5400 |
35680 |
|
|
| KDMN |
Kadmon Holdings Inc. Common Stock |
$4.6800 |
3344822 |
|
|
| KDNY |
Chinook Therapeutics Inc. Common Stock |
$38.8000 |
586220 |
|
|
| KIDS |
OrthoPediatrics Corp. Common Stock |
$44.0100 |
48530 |
|
|
| KIN |
Kindred Biosciences Inc. Common Stock |
$47.6200 |
13240 |
|
|
| KLDO |
Kaleido Biosciences Inc. Common Stock |
$0.0014 |
10670 |
|
|
| KMPH |
KemPharm Inc. Common Stock |
$5.3100 |
52810 |
|
|
| KNSA |
Kiniksa Pharmaceuticals Ltd. Class A Common Stock |
$15.5900 |
447770 |
|
|
| KNTE |
Kinnate Biopharma Inc. Common Stock |
$3.1800 |
195810 |
|
|
| KOD |
Kodiak Sciences Inc Common Stock |
$7.4400 |
502640 |
|
|
| KRBP |
Kiromic BioPharma Inc. Common Stock |
$2.6700 |
45850 |
|
|
| KRON |
Kronos Bio Inc. Common Stock |
$2.1800 |
70520 |
|
|
| KROS |
Keros Therapeutics Inc. Common Stock |
$43.0200 |
132840 |
|
|
| KRTX |
Karuna Therapeutics Inc. Common Stock |
$210.2300 |
194190 |
|
|
| KRYS |
Krystal Biotech Inc. Common Stock |
$123.9200 |
267200 |
|
|
| KURA |
Kura Oncology Inc. Common Stock |
$11.0100 |
590370 |
|
|
| KYMR |
Kymera Therapeutics Inc. Common Stock |
$21.0000 |
268010 |
|
|
| KZR |
Kezar Life Sciences Inc. Common Stock |
$2.3100 |
293010 |
|
|
| LAKE |
Lakeland Industries Inc. Common Stock |
$33.1000 |
164924 |
|
|
| LEGN |
Legend Biotech Corporation American Depositary Shares |
$74.6600 |
814570 |
|
|
| LFMD |
LifeMD Inc. Common Stock |
$18.8800 |
1125408 |
|
|
| LFVN |
Lifevantage Corporation Common Stock (Delaware) |
$4.8700 |
17100 |
|
|
| LGVN |
Longeveron Inc. Class A Common Stock |
$8.1900 |
203463 |
|
|
| LHCG |
LHC Group Common Stock |
$163.2400 |
63380 |
|
|
| LHDX |
Lucira Health Inc. Common Stock |
$18.2700 |
306693 |
|
|
| LIFE |
aTyr Pharma Inc. Common Stock |
$2.0700 |
369850 |
|
|
| LIXTW |
Lixte Biotechnology Holdings Inc. Warrants |
$0.9106 |
14101 |
|
|
| LJPC |
La Jolla Pharmaceutical Company Common Stock |
$5.0600 |
148721 |
|
|
| LMAT |
LeMaitre Vascular Inc. Common Stock |
$62.1000 |
181540 |
|
|
| LMNX |
Luminex Corporation Common Stock |
$29.8900 |
643179 |
|
|
| LNTH |
Lantheus Holdings Inc. Common Stock |
$88.2300 |
739420 |
|
|
| LOGC |
LogicBio Therapeutics Inc. Common Stock |
$0.3897 |
66950 |
|
|
| LPTX |
Leap Therapeutics Inc. Common Stock |
$3.0800 |
154440 |
|
|
| LQDA |
Liquidia Corporation Common Stock |
$8.4700 |
399860 |
|
|
| LRMR |
Larimar Therapeutics Inc. Common Stock |
$3.2300 |
65750 |
|
|
| LTRN |
Lantern Pharma Inc. Common Stock |
$4.7000 |
47280 |
|
|
| LUNA |
Luna Innovations Incorporated Common Stock |
$8.5100 |
96580 |
|
|
| LUNG |
Pulmonx Corporation Common Stock |
$12.5900 |
129410 |
|
|
| LXRX |
Lexicon Pharmaceuticals Inc. Common Stock |
$2.0800 |
1510000 |
|
|
| LYRA |
Lyra Therapeutics Inc. Common Stock |
$3.3000 |
1110000 |
|
|
| MACK |
Merrimack Pharmaceuticals Inc. Common Stock |
$11.8900 |
80870 |
|
|
| MASI |
Masimo Corporation Common Stock |
$114.1000 |
1990000 |
|
|
| MBIO |
Mustang Bio Inc. Common Stock |
$3.5900 |
2004989 |
|
|
| MBRX |
Moleculin Biotech Inc. Common Stock |
$0.6500 |
449930 |
|
|
| MCRB |
Seres Therapeutics Inc. Common Stock |
$4.6000 |
1350000 |
|
|
| MDGL |
Madrigal Pharmaceuticals Inc. Common Stock |
$215.7500 |
160130 |
|
|
| MDVL |
MedAvail Holdings Inc. Common Stock |
$0.2750 |
27600 |
|
|
| MDXG |
MiMedx Group Inc Common Stock |
$7.6000 |
941340 |
|
|
| MEDP |
Medpace Holdings Inc. Common Stock |
$245.2800 |
352350 |
|
|
| MEDS |
Trxade Group Inc. Common Stock |
$6.4500 |
42737 |
|
|
| MEIP |
MEI Pharma Inc. Common Stock |
$0.5027 |
1460000 |
|
|
| MGLN |
Magellan Health Inc. Common Stock |
$93.0000 |
317028 |
|
|
| MGNX |
MacroGenics Inc. Common Stock |
$4.9000 |
273560 |
|
|
| MGTA |
Magenta Therapeutics Inc. Common Stock |
$0.7906 |
106890 |
|
|
| MGTX |
MeiraGTx Holdings plc Ordinary Shares |
$7.1900 |
94920 |
|
|
| MIRM |
Mirum Pharmaceuticals Inc. Common Stock |
$25.6100 |
700220 |
|
|
| MITO |
Stealth BioTherapeutics Corp. ADS |
$0.2400 |
838070 |
|
|
| MLND |
Millendo Therapeutics Inc. Common Stock |
$2.0700 |
277028 |
|
|
| MMSI |
Merit Medical Systems Inc. Common Stock |
$82.0000 |
322110 |
|
|
| MNKD |
MannKind Corporation Common Stock |
$4.4600 |
1590000 |
|
|
| MNOV |
Medicinova Inc Common Stock |
$2.5600 |
13000 |
|
|
| MORF |
Morphic Holding Inc. Common Stock |
$56.8700 |
257579 |
|
|
| MRKR |
Marker Therapeutics Inc. Common Stock |
$6.6100 |
87470 |
|
|
| MRNA |
Moderna Inc. Common Stock |
$126.6000 |
7270000 |
|
|
| MRNS |
Marinus Pharmaceuticals Inc. Common Stock |
$10.0500 |
415800 |
|
|
| MRSN |
Mersana Therapeutics Inc. Common Stock |
$3.7393 |
1430000 |
|
|
| MRTX |
Mirati Therapeutics Inc. Common Stock |
$202.2400 |
214429 |
|
|
| MRVI |
Maravai LifeSciences Holdings Inc. Class A Common Stock |
$12.4500 |
1650000 |
|
|
| MTCR |
Metacrine Inc. Common Stock |
$0.5090 |
142090 |
|
|
| MYGN |
Myriad Genetics Inc. Common Stock |
$23.0800 |
657840 |
|
|
| NAOV |
NanoVibronix Inc. Common Stock |
$3.5000 |
3160 |
|
|
| NARI |
Inari Medical Inc. Common Stock |
$58.4000 |
836810 |
|
|
| NBIX |
Neurocrine Biosciences Inc. Common Stock |
$98.7900 |
714900 |
|
|
| NDRA |
ENDRA Life Sciences Inc. Common Stock |
$1.3600 |
25820 |
|
|
| NDRAW |
ENDRA Life Sciences Inc. Warrants |
$0.4900 |
15049 |
|
|
| NEOS |
Neos Therapeutics Inc. Common Stock |
$0.8441 |
1188676 |
|
|
| NEPH |
Nephros Inc. Common Stock |
$8.2800 |
3852 |
|
|
| NERV |
Minerva Neurosciences Inc Common Stock |
$8.7000 |
113950 |
|
|
| NEXI |
NexImmune Inc. Common Stock |
$0.2901 |
39920 |
|
|
| NGM |
NGM Biopharmaceuticals Inc. Common Stock |
$2.6000 |
137500 |
|
|
| NKTR |
Nektar Therapeutics Common Stock |
$0.5521 |
1330000 |
|
|
| NKTX |
Nkarta Inc. Common Stock |
$2.1200 |
525520 |
|
|
| NMTR |
9 Meters Biopharma Inc. Common Stock |
$1.6300 |
3300637 |
|
|
| NOVN |
Novan Inc. Common Stock |
$0.1335 |
3000000 |
|
|
| NRBO |
NeuroBo Pharmaceuticals Inc. Common Stock |
$0.5100 |
336300 |
|
|
| NRC |
National Research Corporation Common Stock |
$54.1300 |
100612 |
|
|
| NSTG |
NanoString Technologies Inc. Common Stock |
$74.1500 |
937002 |
|
|
| NTLA |
Intellia Therapeutics Inc. Common Stock |
$43.4000 |
838940 |
|
|
| NTRA |
Natera Inc. Common Stock |
$50.8500 |
675830 |
|
|
| NTUS |
Natus Medical Incorporated Common Stock |
$32.9600 |
0 |
|
|
| NURO |
NeuroMetrix Inc. Common Stock |
$0.9730 |
17610 |
|
|
| NUVA |
NuVasive Inc. Common Stock |
$43.0800 |
608580 |
|
|
| NVAX |
Novavax Inc. Common Stock |
$8.1200 |
4300000 |
|
|
| NVIV |
InVivo Therapeutics Holdings Corp Common Stock |
$1.3100 |
8430 |
|
|
| OBLN |
Obalon Therapeutics Inc. Common Stock |
$3.5500 |
119616 |
|
|
| OCDX |
Ortho Clinical Diagnostics plc Ordinary Shares |
$17.5700 |
1595776 |
|
|
| OCGN |
Ocugen Inc. Common Stock |
$0.6098 |
6170000 |
|
|
| OCUL |
Ocular Therapeutix Inc. Common Stock |
$4.6300 |
722050 |
|
|
| ODT |
Odonate Therapeutics Inc. Common Stock |
$19.1000 |
244566 |
|
|
| OM |
Outset Medical Inc. Common Stock |
$19.2900 |
229750 |
|
|
| OMER |
Omeros Corporation Common Stock |
$5.5600 |
271840 |
|
|
| ONCR |
Oncorus Inc. Common Stock |
$1.2500 |
25770 |
|
|
| ONCS |
OncoSec Medical Incorporated Common Stock |
$0.7220 |
4170 |
|
|
| ONCT |
Oncternal Therapeutics Inc. Common Stock |
$1.0200 |
220290 |
|
|
| ONEM |
1Life Healthcare Inc. Common Stock |
$16.7600 |
12480000 |
|
|
| ONTX |
Onconova Therapeutics Inc. Common Stock |
$1.0500 |
130840 |
|
|
| ONTXW |
Onconova Therapeutics Inc. Warrants |
$0.3771 |
60145 |
|
|
| ONVO |
Organovo Holdings Inc. Common Stock |
$1.9300 |
17950 |
|
|
| OPCH |
Option Care Health Inc. Common Stock |
$33.0500 |
1830000 |
|
|
| OPGN |
OpGen Inc. Common Stock |
$0.6100 |
96220 |
|
|
| OPNT |
Opiant Pharmaceuticals Inc. Common Stock |
$10.1600 |
5430 |
|
|
| OPTN |
OptiNose Inc. Common Stock |
$1.0700 |
674990 |
|
|
| ORGO |
Organogenesis Holdings Inc. Class A Common Stock |
$4.3500 |
411100 |
|
|
| ORGS |
Orgenesis Inc. Common Stock |
$7.0700 |
45676 |
|
|
| ORIC |
Oric Pharmaceuticals Inc. Common Stock |
$8.5500 |
454380 |
|
|
| OSMT |
Osmotica Pharmaceuticals plc Ordinary Shares |
$3.7400 |
304323 |
|
|
| OSUR |
OraSure Technologies Inc. Common Stock |
$11.0800 |
2485105 |
|
|
| OTIC |
Otonomy Inc. Common Stock |
$1.8500 |
757100 |
|
|
| OTLKW |
Outlook Therapeutics Inc. Series A Warrant Expiring 02/18/2022 |
$0.9900 |
40416 |
|
|
| OTRK |
Ontrak Inc. Common Stock |
$28.8600 |
4340189 |
|
|
| OTRKP |
Ontrak Inc. 9.50% Series A Cumulative Perpetual Preferred Stock |
$22.4500 |
71465 |
|
|
| OVID |
Ovid Therapeutics Inc. Common Stock |
$3.4800 |
137530 |
|
|
| OYST |
Oyster Point Pharma Inc. Common Stock |
$5.5000 |
36720 |
|
|
| PAND |
Pandion Therapeutics Inc. Common Stock |
$61.2300 |
358842 |
|
|
| PASG |
Passage Bio Inc. Common Stock |
$1.0200 |
147240 |
|
|
| PAVM |
PAVmed Inc. Common Stock |
$0.3952 |
220360 |
|
|
| PAVMW |
PAVmed Inc. Warrant |
$1.3100 |
31877 |
|
|
| PAVMZ |
PAVmed Inc. Series Z Warrant |
$2.8100 |
178288 |
|
|
| PBYI |
Puma Biotechnology Inc Common Stock |
$3.6400 |
137350 |
|
|
| PCRX |
Pacira BioSciences Inc. Common Stock |
$37.0700 |
901070 |
|
|
| PCSA |
Processa Pharmaceuticals Inc. Common Stock |
$0.3752 |
376390 |
|
|
| PCVX |
Vaxcyte Inc. Common Stock |
$47.8700 |
564230 |
|
|
| PDCO |
Patterson Companies Inc. Common Stock |
$32.3600 |
937484 |
|
|
| PDEX |
Pro-Dex Inc. Common Stock |
$25.7600 |
17287 |
|
|
| PDSB |
PDS Biotechnology Corporation Common Stock |
$5.5500 |
647000 |
|
|
| PETS |
PetMed Express Inc. Common Stock |
$13.8500 |
313820 |
|
|
| PGEN |
Precigen Inc. Common Stock |
$1.3800 |
1150000 |
|
|
| PGNY |
Progyny Inc. Common Stock |
$39.6200 |
489340 |
|
|
| PHAS |
PhaseBio Pharmaceuticals Inc. Common Stock |
$1.1400 |
144730 |
|
|
| PHIO |
Phio Pharmaceuticals Corp. Common Stock |
$0.7222 |
455110 |
|
|
| PHIOW |
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 |
$0.3600 |
90261 |
|
|
| PLRX |
Pliant Therapeutics Inc. Common Stock |
$17.9100 |
332760 |
|
|
| PLSE |
Pulse Biosciences Inc Common Stock (DE) |
$6.6500 |
86900 |
|
|
| PLXP |
PLx Pharma Inc. Common Stock |
$2.2000 |
64500 |
|
|
| PMD |
Psychemedics Corporation |
$7.2000 |
21454 |
|
|
| PNTG |
The Pennant Group Inc. Common Stock |
$11.6200 |
100930 |
|
|
| POAI |
Predictive Oncology Inc. Common Stock |
$6.1600 |
100710 |
|
|
| PODD |
Insulet Corporation Common Stock |
$285.2700 |
389340 |
|
|
| PPD |
PPD Inc. Common Stock |
$35.9900 |
1205776 |
|
|
| PRAH |
PRA Health Sciences Inc. Common Stock |
$142.8100 |
1989191 |
|
|
| PRAX |
Praxis Precision Medicines Inc. Common Stock |
$1.0700 |
533110 |
|
|
| PRLD |
Prelude Therapeutics Incorporated Common Stock |
$4.5700 |
16910 |
|
|
| PROG |
Progenity Inc. Common Stock |
$0.0000 |
0 |
|
|
| PRTA |
Prothena Corporation plc Ordinary Shares |
$63.7100 |
295940 |
|
|
| PRTK |
Paratek Pharmaceuticals Inc. Common Stock |
$2.1800 |
565450 |
|
|
| PRVB |
Provention Bio Inc. Common Stock |
$4.1100 |
1090000 |
|
|
| PSNL |
Personalis Inc. Common Stock |
$2.3600 |
134530 |
|
|
| PSTV |
PLUS THERAPEUTICS Inc. Common Stock |
$2.7100 |
272611 |
|
|
| PSTX |
Poseida Therapeutics Inc. Common Stock |
$1.9700 |
446480 |
|
|
| PTCT |
PTC Therapeutics Inc. Common Stock |
$57.3200 |
407074 |
|
|
| PTE |
PolarityTE Inc. Common Stock |
$1.3200 |
64280 |
|
|
| PTGX |
Protagonist Therapeutics Inc. Common Stock |
$20.2300 |
947130 |
|
|
| PTPI |
Petros Pharmaceuticals Inc. Common Stock |
$3.4200 |
52384 |
|
|
| QDEL |
Quidel Corporation Common Stock |
$87.9400 |
594320 |
|
|
| QLGN |
Qualigen Therapeutics Inc. Common Stock |
$1.0400 |
50360 |
|
|
| RARE |
Ultragenyx Pharmaceutical Inc. Common Stock |
$43.2000 |
496640 |
|
|
| RCKT |
Rocket Pharmaceuticals Inc. Common Stock |
$18.4500 |
502140 |
|
|
| RDNT |
RadNet Inc. Common Stock |
$34.9900 |
870910 |
|
|
| RDUS |
Radius Health Inc. Common Stock |
$10.0800 |
519760 |
|
|
| REGN |
Regeneron Pharmaceuticals Inc. Common Stock |
$734.6300 |
1810000 |
|
|
| REPH |
Recro Pharma Inc. Common Stock |
$3.7700 |
658148 |
|
|
| REPL |
Replimune Group Inc. Common Stock |
$20.7600 |
480210 |
|
|
| RETA |
Reata Pharmaceuticals Inc. Class A Common Stock |
$109.7500 |
226500 |
|
|
| RGEN |
Repligen Corporation Common Stock |
$212.6500 |
296060 |
|
|
| RGLS |
Regulus Therapeutics Inc. Common Stock |
$1.5000 |
25100 |
|
|
| RGNX |
REGENXBIO Inc. Common Stock |
$18.2700 |
201270 |
|
|
| RLAY |
Relay Therapeutics Inc. Common Stock |
$12.3900 |
672880 |
|
|
| RMTI |
Rockwell Medical Inc. (DE) Common Stock |
$4.0500 |
1090000 |
|
|
| RPRX |
Royalty Pharma plc Class A Ordinary Shares |
$31.0600 |
1750000 |
|
|
| RUBY |
Rubius Therapeutics Inc. Common Stock |
$0.7017 |
140300 |
|
|
| RVMD |
Revolution Medicines Inc. Common Stock |
$26.7700 |
620080 |
|
|
| RVNC |
Revance Therapeutics Inc. Common Stock |
$22.7100 |
928990 |
|
|
| RVPH |
Reviva Pharmaceuticals Holdings Inc. Common Stock |
$4.8300 |
34690 |
|
|
| RVPHW |
Reviva Pharmaceuticals Holdings Inc. Warrants |
$0.6901 |
19800 |
|
|
| RYTM |
Rhythm Pharmaceuticals Inc. Common Stock |
$17.8200 |
394050 |
|
|
| RZLT |
Rezolute Inc. Common Stock |
$1.9600 |
5780 |
|
|
| SAGE |
Sage Therapeutics Inc. Common Stock |
$45.2500 |
425710 |
|
|
| SANA |
Sana Biotechnology Inc. Common Stock |
$5.9600 |
628130 |
|
|
| SAVA |
Cassava Sciences Inc. Common Stock |
$21.4600 |
516700 |
|
|
| SBBP |
Strongbridge Biopharma plc Ordinary Shares |
$3.1200 |
1009333 |
|
|
| SBTX |
Silverback Therapeutics Inc. Common Stock |
$4.1410 |
235340 |
|
|
| SCPH |
scPharmaceuticals Inc. Common Stock |
$8.2700 |
236020 |
|
|
| SCPS |
Scopus BioPharma Inc. Common Stock |
$0.3800 |
160070 |
|
|
| SCYX |
SCYNEXIS Inc. Common Stock |
$2.8300 |
133130 |
|
|
| SDC |
SmileDirectClub Inc. Class A Common Stock |
$0.7000 |
974530 |
|
|
| SDGR |
Schrodinger Inc. Common Stock |
$53.9800 |
1370000 |
|
|
| SEEL |
Seelos Therapeutics Inc. Common Stock |
$3.0200 |
1301507 |
|
|
| SESN |
Sesen Bio Inc. Common Stock |
$0.6334 |
1450000 |
|
|
| SGEN |
Seagen Inc. Common Stock |
$153.7100 |
1697091 |
|
|
| SGMO |
Sangamo Therapeutics Inc. Common Stock |
$1.3700 |
1370000 |
|
|
| SGRY |
Surgery Partners Inc. Common Stock |
$40.0700 |
891470 |
|
|
| SGTX |
Sigilon Therapeutics Inc. Common Stock |
$21.1900 |
23460 |
|
|
| SHC |
Sotera Health Company Common Stock |
$19.0500 |
574370 |
|
|
| SIBN |
SI-BONE Inc. Common Stock |
$24.8100 |
205490 |
|
|
| SILK |
Silk Road Medical Inc. Common Stock |
$20.3000 |
1020000 |
|
|
| SLDB |
Solid Biosciences Inc. Common Stock |
$4.9500 |
6640 |
|
|
| SLNO |
Soleno Therapeutics Inc. Common Stock |
$5.0000 |
12980 |
|
|
| SLRX |
Salarius Pharmaceuticals Inc. Common Stock |
$1.1500 |
32619 |
|
|
| SLS |
SELLAS Life Sciences Group Inc. Common Stock |
$9.4400 |
1527374 |
|
|
| SMTI |
Sanara MedTech Inc. Common Stock |
$32.1500 |
35524 |
|
|
| SNCA |
Seneca Biopharma Inc. Common Stock |
$1.3800 |
1365068 |
|
|
| SNDX |
Syndax Pharmaceuticals Inc. Common Stock |
$21.2600 |
427480 |
|
|
| SNGXW |
Soligenix Inc. Warrant |
$0.3890 |
22750 |
|
|
| SNSE |
Sensei Biotherapeutics Inc. Common Stock |
$1.2300 |
14850 |
|
|
| SOLY |
Soliton Inc. Common Stock |
$13.5500 |
219168 |
|
|
| SPNE |
SeaSpine Holdings Corporation Common Stock |
$5.9300 |
70990 |
|
|
| SPPI |
Spectrum Pharmaceuticals Inc.Common Stock |
$1.0000 |
875380 |
|
|
| SPRB |
Spruce Biosciences Inc. Common Stock |
$2.2100 |
39190 |
|
|
| SPRO |
Spero Therapeutics Inc. Common Stock |
$1.5200 |
247830 |
|
|
| SRDX |
Surmodics Inc. Common Stock |
$31.8500 |
63240 |
|
|
| SRGA |
Surgalign Holdings Inc. Common Stock |
$3.1400 |
28580 |
|
|
| SRNE |
Sorrento Therapeutics Inc. Common Stock |
$2.5900 |
4810000 |
|
|
| SRPT |
Sarepta Therapeutics Inc. Common Stock (DE) |
$105.8600 |
1080000 |
|
|
| SRRK |
Scholar Rock Holding Corporation Common Stock |
$7.0400 |
170870 |
|
|
| SRTS |
Sensus Healthcare Inc. Common Stock |
$4.9300 |
297557 |
|
|
| SSKN |
Strata Skin Sciences Inc. Common Stock |
$1.1600 |
1380000 |
|
|
| STAA |
STAAR Surgical Company Common Stock |
$103.7500 |
353026 |
|
|
| STIM |
Neuronetics Inc. Common Stock |
$2.0010 |
111920 |
|
|
| STOK |
Stoke Therapeutics Inc. Common Stock |
$11.9900 |
685410 |
|
|
| STRR |
Star Equity Holdings Inc. Common Stock |
$0.9900 |
119500 |
|
|
| STRRP |
Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock |
$9.5500 |
1 |
|
|
| STTK |
Shattuck Labs Inc. Common Stock |
$2.7400 |
8050 |
|
|
| SUPN |
Supernus Pharmaceuticals Inc. Common Stock |
$30.6100 |
271450 |
|
|
| SURF |
Surface Oncology Inc. Common Stock |
$0.9690 |
127190 |
|
|
| SVRA |
Savara Inc. Common Stock |
$3.4300 |
370290 |
|
|
| SWAV |
ShockWave Medical Inc. Common Stock |
$278.3000 |
437250 |
|
|
| SWTX |
SpringWorks Therapeutics Inc. Common Stock |
$30.2300 |
378040 |
|
|
| SYBX |
Synlogic Inc. Common Stock |
$0.4922 |
157110 |
|
|
| SYNH |
Syneos Health Inc. Class A Common Stock |
$42.3500 |
887000 |
|
|
| TARA |
Protara Therapeutics Inc. Common Stock |
$2.7500 |
13660 |
|
|
| TARS |
Tarsus Pharmaceuticals Inc. Common Stock |
$24.7800 |
397690 |
|
|
| TBIO |
Translate Bio Inc. Common Stock |
$1.3200 |
118920 |
|
|
| TCDA |
Tricida Inc. Common Stock |
$9.4000 |
191200 |
|
|
| TCMD |
Tactile Systems Technology Inc. Common Stock |
$22.7700 |
432870 |
|
|
| TCON |
TRACON Pharmaceuticals Inc. Common Stock |
$0.3010 |
808970 |
|
|
| TCRR |
TCR2 Therapeutics Inc. Common Stock |
$3.1700 |
105420 |
|
|
| TELA |
TELA Bio Inc. Common Stock |
$10.6800 |
241610 |
|
|
| TENX |
Tenax Therapeutics Inc. Common Stock |
$0.3210 |
212500 |
|
|
| TERN |
Terns Pharmaceuticals Inc. Common Stock |
$7.8700 |
469360 |
|
|
| TFFP |
TFF Pharmaceuticals Inc. Common Stock |
$0.3447 |
299980 |
|
|
| TLGT |
Teligent Inc. Common Stock |
$0.9149 |
2247312 |
|
|
| TLMD |
SOC Telemed Inc. Class A Common Stock |
$7.8400 |
364847 |
|
|
| TLMDW |
SOC Telemed Inc. Warrants |
$1.3800 |
24597 |
|
|
| TMDX |
TransMedics Group Inc. Common Stock |
$92.2500 |
316770 |
|
|
| TNDM |
Tandem Diabetes Care Inc. Common Stock |
$33.0600 |
2280000 |
|
|
| TNXP |
Tonix Pharmaceuticals Holding Corp. Common Stock |
$1.6590 |
66150 |
|
|
| TPTX |
Turning Point Therapeutics Inc. Common Stock |
$74.8700 |
420170 |
|
|
| TRUP |
Trupanion Inc. Common Stock |
$95.9100 |
403342 |
|
|
| TRVI |
Trevi Therapeutics Inc. Common Stock |
$2.3500 |
95350 |
|
|
| TSHA |
Taysha Gene Therapies Inc. Common Stock |
$0.6999 |
119730 |
|
|
| TTOO |
T2 Biosystems Inc. Common Stock |
$0.1013 |
95260000 |
|
|
| TVTX |
Travere Therapeutics Inc. Common Stock |
$16.1200 |
1210000 |
|
|
| TVTY |
Tivity Health Inc. Common Stock |
$23.1700 |
272107 |
|
|
| TWST |
Twist Bioscience Corporation Common Stock |
$24.7800 |
959970 |
|
|
| TXMD |
TherapeuticsMD Inc. Common Stock |
$4.0800 |
26550 |
|
|
| TYME |
Tyme Technologies Inc. Common Stock |
$2.0000 |
3753765 |
|
|
| UBX |
Unity Biotechnology Inc. Common Stock |
$3.0100 |
122490 |
|
|
| UFPT |
UFP Technologies Inc. Common Stock |
$193.5800 |
76980 |
|
|
| UTHR |
United Therapeutics Corporation Common Stock |
$166.5900 |
184077 |
|
|
| VCEL |
Vericel Corporation Common Stock |
$38.2900 |
231680 |
|
|
| VCNX |
Vaccinex Inc. Common Stock |
$0.2966 |
287280 |
|
|
| VCYT |
Veracyte Inc. Common Stock |
$28.5800 |
486100 |
|
|
| VERO |
Venus Concept Inc. Common Stock |
$2.6700 |
341145 |
|
|
| VERU |
Veru Inc. Common Stock |
$1.2900 |
938800 |
|
|
| VIE |
Viela Bio Inc. Common Stock |
$52.9300 |
381910 |
|
|
| VINC |
Vincerx Pharma Inc. Common Stock |
$1.3500 |
18780 |
|
|
| VINCU |
Vincerx Pharma Inc. Unit |
$30.9000 |
1 |
|
|
| VINCW |
Vincerx Pharma Inc. Warrant |
$4.1000 |
19317 |
|
|
| VIVE |
Viveve Medical Inc. Common Stock |
$0.6319 |
37760 |
|
|
| VIVO |
Meridian Bioscience Inc. Common Stock |
$32.4600 |
201800 |
|
|
| VKTXW |
Viking Therapeutics Inc. Warrants |
$5.4300 |
6221 |
|
|
| VLON |
Vallon Pharmaceuticals Inc. Common Stock |
$0.4600 |
52060 |
|
|
| VMD |
Viemed Healthcare Inc. Common Shares |
$9.7700 |
158719 |
|
|
| VOR |
Vor Biopharma Inc. Common Stock |
$3.3400 |
191330 |
|
|
| VRAY |
ViewRay Inc. Common Stock |
$0.0500 |
70460000 |
|
|
| VRCA |
Verrica Pharmaceuticals Inc. Common Stock |
$14.2600 |
48646 |
|
|
| VRDN |
Viridian Therapeutics Inc. Common Stock |
$16.7400 |
11155 |
|
|
| VRPX |
Virpax Pharmaceuticals Inc. Common Stock |
$5.5100 |
57299 |
|
|
| VRTX |
Vertex Pharmaceuticals Incorporated Common Stock |
$362.6000 |
4430000 |
|
|
| VSTM |
Verastem Inc. Common Stock |
$9.7500 |
223650 |
|
|
| VTGN |
VistaGen Therapeutics Inc. Common Stock |
$1.8800 |
56090 |
|
|
| VTVT |
vTv Therapeutics Inc. Class A Common Stock |
$0.7388 |
37140 |
|
|
| VVOS |
Vivos Therapeutics Inc. Common Stock |
$7.2400 |
53008 |
|
|
| VXRT |
Vaxart Inc Common Stock |
$0.8250 |
991400 |
|
|
| VYGR |
Voyager Therapeutics Inc. Common Stock |
$9.1000 |
602690 |
|
|
| VYNE |
VYNE Therapeutics Inc. Common Stock |
$4.0600 |
17390 |
|
|
| WBA |
Walgreens Boots Alliance Inc. Common Stock |
$30.4600 |
17540000 |
|
|
| WINT |
Windtree Therapeutics Inc. Common Stock |
$1.3900 |
77930 |
|
|
| XAIR |
Beyond Air Inc. Common Stock |
$4.0400 |
367770 |
|
|
| XBIOW |
Xenetic Biosciences Inc. Warrants |
$2.7714 |
1337 |
|
|
| XBIT |
XBiotech Inc. Common Stock |
$5.2100 |
20960 |
|
|
| XCUR |
Exicure Inc. Common Stock |
$1.0800 |
46520 |
|
|
| XENT |
Intersect ENT Inc. Common Stock |
$24.0000 |
253807 |
|
|
| XERS |
Xeris Pharmaceuticals Inc. Common Stock |
$5.1000 |
2925604 |
|
|
| XFOR |
X4 Pharmaceuticals Inc. Common Stock |
$1.8000 |
1780000 |
|
|
| XGN |
Exagen Inc. Common Stock |
$2.8100 |
32380 |
|
|
| XLRN |
Acceleron Pharma Inc. Common Stock |
$135.8500 |
417004 |
|
|
| XNCR |
Xencor Inc. Common Stock |
$23.9400 |
219600 |
|
|
| XOMAP |
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock |
$25.5700 |
3318 |
|
|
| XRAY |
DENTSPLY SIRONA Inc. Common Stock |
$40.7600 |
1200000 |
|
|
| YMAB |
Y-mAbs Therapeutics Inc. Common Stock |
$6.5800 |
264240 |
|
|
| YMTX |
Yumanity Therapeutics Inc. Common Stock |
$17.9000 |
82749 |
|
|
| ZGNX |
Zogenix Inc. Common Stock |
$20.4300 |
519612 |
|
|
| ZIOP |
ZIOPHARM Oncology Inc Common Stock |
$5.0700 |
2772552 |
|
|
| ZNTL |
Zentalis Pharmaceuticals Inc. Common Stock |
$26.1900 |
523440 |
|
|
| ZSAN |
Zosano Pharma Corporation Common Stock |
$1.2500 |
3893212 |
|
|
| ZYNE |
Zynerba Pharmaceuticals Inc. Common Stock |
$0.3700 |
78320 |
|
|
